Search research articles
Contact Us
Filters
Showing results (141-150 of 156) with videos related to
Page
of 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)
P Baas, A Ardizzoni, F Grossi, et al.
International Journal of Immunopathology and Pharmacology
|
October 4, 2014
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array
A Ardizzoni, B Posteraro, M C Baschieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2021
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>
A-M C Dingemans, M Früh, A Ardizzoni, et al.
La Radiologia Medica
|
September 27, 2008
Advantages of multidetector-row CT with multiplanar reformation in guiding percutaneous lung biopsies
M De Filippo, M Onniboni, M Rusca, et al.
The Pharmacogenomics Journal
|
July 6, 2016
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
A Musolino, N Naldi, M V Dieci, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 2, 2017
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
Pietro Ghedini, I Bossert, L Zanoni, et al.
International Journal of Oncology
|
April 30, 2011
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines
M Loprevite, L Varesco, R Favoni, et al.
Endocrine-Related Cancer
|
December 18, 2013
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
G Rindi, C Klersy, F Inzani, et al.
ESMO Open
|
November 18, 2025
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50
A De Giglio, L Zullo, A Di Federico, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group
T Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 156) with videos related to
Sort By:
Page
of 16
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)
P Baas, A Ardizzoni, F Grossi, et al.
International Journal of Immunopathology and Pharmacology
|
October 4, 2014
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array
A Ardizzoni, B Posteraro, M C Baschieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2021
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>
A-M C Dingemans, M Früh, A Ardizzoni, et al.
La Radiologia Medica
|
September 27, 2008
Advantages of multidetector-row CT with multiplanar reformation in guiding percutaneous lung biopsies
M De Filippo, M Onniboni, M Rusca, et al.
The Pharmacogenomics Journal
|
July 6, 2016
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
A Musolino, N Naldi, M V Dieci, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 2, 2017
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
Pietro Ghedini, I Bossert, L Zanoni, et al.
International Journal of Oncology
|
April 30, 2011
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines
M Loprevite, L Varesco, R Favoni, et al.
Endocrine-Related Cancer
|
December 18, 2013
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
G Rindi, C Klersy, F Inzani, et al.
ESMO Open
|
November 18, 2025
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50
A De Giglio, L Zullo, A Di Federico, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group
T Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Page
of 16